Topical Pain Relief


ZTlido Labeling Updated With Clinical Data on Water Exposure

The Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ZTlido® (lidocaine topical system; Scilex Pharmaceuticals) to include additional administration-related data. ZTlido is indicated for the relief of pain associated with postherpetic neuralgia in adults. The product is available as a single-layer, drug-in-adhesive topical delivery system containing 36mg of lidocaine in a…